Emergent Health Corp (EMGE)

USD 0.0

(0.0%)

Market Cap (In USD)

33.54 Thousand

Revenue (In USD)

1.63 Million

Net Income (In USD)

-1.62 Million

Avg. Volume

1.37 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
6.0E-4-0.0041
PE
-
EPS
-
Beta Value
1.063
ISIN
US29100Q3083
CUSIP
29100Q308
CIK
1463459
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. James W. Zimbler
Employee Count
-
Website
https://www.emergenthealthcorp.com
Ipo Date
2009-09-08
Details
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.